-$16.15 (-4.99%)
Industry, Sector & symbol
Stock Exchange | National Stock Exchange of India |
CEO | Dr. Rajesh Jain Ph.D. |
Industry | Biotechnology |
Sector | Healthcare |
Current Symbol | PANACEABIO.NS |
CUSIP | Y6695F130 |
CIK | None |
Web | https://www.panaceabiotec.com |
Phone | 91 11 4167 9000 |
Currency | INR |
Employees | 1936 |
Country | IN |
Liquidity
Debt-to-Equity Ratio | 0.02 |
Payout Ratio | 0.00 |
Current Ratio | 1.57 |
Quick Ratio | 0.99 |
Cash Ratio | 0.45 |
Sales & Book Value
Annual Sales | $5.59B |
Price / Sales | 3.45 |
Cash Flow | 9.11 |
Price / Cash Flow | 33.72 |
Price / Book | 2.23 |
Price Target and Rating
Average Stock Price Forecast | $ |
High Stock Price Forecast | $ |
Low Stock Price Forecast | $ |
Forecast Upside/Downside | % |
Consensus Rating | Strong Sell |
Rating Score(0-5) | 1 |
Research Coverage | 0 Analysts |
Profitability
EPS (Most Recent Fiscal Year) | $-0.19 |
Trailing P/E Ratio | -67.68 |
PEG Ratio | -0.70 |
P/E Growth | -0.70 |
Net Income | $-11.7M |
Net Margin | -5.09% |
Pretax Margin | -5.24% |
Return on Equity | -3.30% |
Return on Assets | -2.24% |
Financials Score
AltmanZ Score | 3.27 |
Piotroski Score | 3.00 |
Working Capital | 1.76B |
Total Assets | 12.41B |
Ebit | -564.7M |
Market Cap | 18.82B |
Total Liabilities | 4.02B |
About Panacea Biotec Limited (NSE:PANACEABIO.NS) Stock
Panacea Biotec Limited, a biotechnology company, engages in the research and development, manufacture, and marketing of pharmaceuticals, vaccines, and biosimilars in India. It operates through Vaccines and Formulations segments. The company's product portfolio includes prescription products in various therapeutic areas, such as pain management, diabetes and cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, and gastro-intestinal care; and vaccines for anthrax, dengue, Japanese encephalitis, and others. It also exports its products to over 30 countries worldwide, including the United States, Germany, the Russian Federation, Sri Lanka, the Philippines, etc. The company has a collaboration agreement with the Russian Direct Investment Fund ... for producing Covid-19 vaccine Sputnik-V; and the Coalition for Epidemic Preparedness Innovations and Translational Health Science and Technology Institute to develop vaccine candidates that could protect against SARS-Cov-2 variants and other Beta coronaviruses. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.
Frequently Asked Questions
What is the current Panacea Biotec Limited (PANACEABIO.NS) stock price?
Panacea Biotec Limited(NSE:PANACEABIO.NS) stock price is $307.2 in the last trading session. During the trading session, PANACEABIO.NS stock reached the peak price of $367.27 while $112.35 was the lowest point it dropped to. The percentage change in PANACEABIO.NS stock occurred in the recent session was --4.99% while the dollar amount for the price change in PANACEABIO.NS stock was -$-16.15.
PANACEABIO.NS's industry and sector of operation?
The NSE listed PANACEABIO.NS is part of Biotechnology industry that operates in the broader Healthcare sector.
Who are the executives of PANACEABIO.NS?
Mr. Ankesh Jain
| Whole-Time Director
Dr. Rajeeva Kumar Mangalum
| Chief Operating Officer
Naresh Chand Gupta
| General Manager of Accounts & Taxation
Mr. Gurinder Pal Singh
| Senior Vice President of Sales
Mr. Devender Gupta
| Chief Financial Officer & Head of Information Technology
How many employees does PANACEABIO.NS have?
Number of PANACEABIO.NS employees currently stands at 1936. PANACEABIO.NS operates from B-1 Extension/G-3, New Delhi, None 110044, IN.
Link for PANACEABIO.NS official website?
Official Website of PANACEABIO.NS is: https://www.panaceabiotec.com
How do I contact PANACEABIO.NS?
PANACEABIO.NS could be contacted at phone #91 11 4167 9000 and can also be accessed through its website. PANACEABIO.NS operates from B-1 Extension/G-3, New Delhi, None 110044, IN.
How many shares of PANACEABIO.NS are traded daily?
The average number of PANACEABIO.NS shares traded daily for last 3 months was 850.1K.
What is the market cap of PANACEABIO.NS currently?
The market value of PANACEABIO.NS currently stands at $18.82B with its latest stock price at $307.2